That makes it the biggest deal for an AI-designed drug in history.
But very few people even know about it...yet.
Even leading investors in the U.S. have no idea.
And they don't know that
this tiny AI-biotech designed the drug.
But this won't stay quiet much longer.
On January 9, 2023,
ristol Myers Squibb signed a $2.7 billion deal to have their AI-platform develop six new drugs.
On October 6, 2022,
Eli Lilly signed a $425 million deal to have their AI-platform develop a new drug.
These seven drugs alone could bring
$28 billion to
this little-known company. That doesn't include deals they signed with
Sanofi, Nimbus Therapeutics, Petra Pharma and others. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business...
Which is why I believe this will be the biggest AI winner you never heard of.
Get the name of the stock here...while it's still a small-cap >>> "The Buck Stops Here,"
